Orlifique (Ethinylestradiol, Levonorgestrel | Lactose)

Ethinylestradiol, the active ingredient in Orlifique, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age. GNH USA supplies Orlifique as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orlifique as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orlifique is a combined oral contraceptive that acts on the hormonal regulation of the menstrual cycle.

- Contraception: Provides reliable prevention of pregnancy when taken as prescribed. - Menstrual cycle regulation: Helps maintain a regular menstrual pattern. - Acne management: May improve acne associated with hormonal fluctuations. - Endometriosis symptom relief: Reduces menstrual‑related pain and bleeding. - Ovarian cyst prevention: Lowers the risk of functional ovarian cyst formation. - Hormone‑dependent tumor ​​​  ​  ​  ​  ​  ​  ​

​     ​  …